Drugs / Cipterbin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05131841 | Jan 2021 → Dec 2022 | breast cancer | Zhejiang Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cipterbin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05131841 ↗ |